Strategies for targeted nonviral delivery of siRNAs in vivo
Authors:
- Himanshu GargHGHimanshu Garg
- Anjali JoshiAJAnjali Joshi
- N. ManjunathNMN. Manjunath
- 1 November 2009
- journal article
- review article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 15 (11) , 491-500
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- Lentiviral delivery of short hairpin RNAsAdvanced Drug Delivery Reviews, 2009
- Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammationNature, 2009
- The promises and pitfalls of RNA-interference-based therapeuticsNature, 2009
- Chitosan/siRNA Nanoparticle–mediated TNF-α Knockdown in Peritoneal Macrophages for Anti-inflammatory Treatment in a Murine Arthritis ModelMolecular Therapy, 2009
- Novel Dual Inhibitory Function Aptamer–siRNA Delivery System for HIV-1 TherapyMolecular Therapy, 2008
- T Cell-Specific siRNA Delivery Suppresses HIV-1 Infection in Humanized MiceCell, 2008
- A combinatorial library of lipid-like materials for delivery of RNAi therapeuticsNature Biotechnology, 2008
- Sequence- and target-independent angiogenesis suppression by siRNA via TLR3Nature, 2008
- shRNA and siRNA delivery to the brainAdvanced Drug Delivery Reviews, 2007
- RNAi therapeutics: Principles, prospects and challengesAdvanced Drug Delivery Reviews, 2007